Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2023 of 5804
-
AI learns to detect stroke risk in real time
Knowledge-focused CompletedIn patients undergoing planned surgery for carotid tromendarterendectomy, a non-invasive device that registers heart rate variability is attached. Furthermore a non-invasive device that monitors cerebral oxygenation- near infrared spectroscopy as well as electroencephalography is…
Sponsor: Linda Block • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Mind over back pain: study tests emotion training as a pain reliever
Symptom relief CompletedThis study will advance understanding on the mechanisms that mediate improved outcomes for chronic low back pain and provide specific directions for optimizing physical activity interventions for this population.
Phase: NA • Sponsor: University of Connecticut • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Which breathing aid works best for tiny preemies? new study compares two methods.
Disease control CompletedNon invasive ventilation is important in the care of preterm infants with respiratory failure, and surfactant treatment can be use with non invasive ventilation. However, there is no consensus on the best non-invasive ventilation mode for surfactant treatment in preterm infants. …
Phase: NA • Sponsor: Uludag University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Rare cancer hope: genetic tests may match patients to better treatments
Knowledge-focused Recruiting nowThis open label, non-randomized, multi-center, pragmatic study aims to establish whether patients with rare tumors can benefit from matched molecular therapy as dictated by their next-generation sequencing (NGS) results.
Phase: NA • Sponsor: TargetCancer Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Heart procedure timing trial aims to reduce complications
Disease control OngoingThe primary objective of this study is to compare, in patients with severe aortic stenosis and concomitant coronary artery disease accepted for transcatheter aortic valve implantation (TAVI) and percutaneous coronary intervention (PCI) by the multidisciplinary Heart Team, the saf…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Goggle gadget aims to spot concussions in minutes
Diagnosis CompletedThis study will establish the capability of a suite of conventional tests and the Neurolign Dx\_100 I-PAS goggle system to reliably and objectively detect mTBI in an acute setting when comparing individuals with mTBI to controls with minor injuries in a similarly stressful enviro…
Phase: NA • Sponsor: Carey Balaban • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Could freezing testicular tissue save fertility for boys and men?
Disease control Recruiting nowThe "Testicular Tissue Cryopreservation" study is open to a subset of patients facing disease or treatment regimens that could lead to infertility (gonadotoxic therapies). For some of these patients, experimental testicular tissue cryopreservation is the only fertility preservati…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 26, 2026 18:02 UTC
-
Gene therapy shot for dry AMD shows promise but trial halted early
Disease control TerminatedThe purpose of this clinical study was to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).
Phase: PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental pill ICP-723 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowA Multicenter, Nonrandomized, Open-Label Phase I/IIClinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients with Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:39 UTC
-
Can two existing drugs help cancer patients ditch steroids?
Symptom relief OngoingThe purpose of this study is to examine how effective rituximab or tocilizumab are in treating side effects for people who are receiving immunotherapy treatment requiring prolonged steroid use. Immune-related side effects are caused by the activation of the immune system. Becaus…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Could farm animals help young adults with autism break out of social isolation?
Symptom relief OngoingNeuropsychiatric impairments in young adults are common and can involve social withdrawal, and difficulties in receiving support from healthcare and municipal social care services. Collaboration is needed, but knowledge gaps exist concerning effective interventions. Participation…
Phase: NA • Sponsor: Kronoberg County Council • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New study probes immune changes in bladder cancer before surgery
Knowledge-focused OngoingThis is an open-label, window of opportunity platform study for subjects with muscle-invasive bladder cancer (MIBC) who are deemed ineligible or refuse cisplatin-based neoadjuvant chemotherapy and are scheduled to undergo definitive surgery (radical cystectomy), or are planning t…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New radiation technique aims to safely prepare blood cancer patients for transplant
Disease control CompletedSingle institution study of safety of linac based VMAT TBI for myeloablative treatment in hematologic malignancies.
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can extra protein save lives in the ICU?
Disease control Recruiting nowThe investigator will investigate the effect of supplemental enteral protein (1.2 g/kg/day) added to standard formula to achieve high amount of enteral protein (range 2-2.4 g/kg/day) given from ICU day 5 until ICU discharge up to ICU day 90 as compared to no supplemental enteral …
Phase: NA • Sponsor: King Abdullah International Medical Research Center • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
Plasma from recovered patients tested against COVID-19 – trial ends early
Disease control TerminatedA prospective, randomized, placebo-controlled, double-blinded, phase III clinical trial of the therapeutic use of convalescent plasma in the treatment of patients with moderate to severe COVID-19
Phase: PHASE3 • Sponsor: South African National Blood Service • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can meditation rewire brain networks? scientists scan for answers
Knowledge-focused CompletedThe purpose of this study is to investigate functional brain network in altered meditation state with multimodal neuroimaging.
Phase: NA • Sponsor: Shanghai Mental Health Center • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Could probiotics help tame fatty liver?
Disease control CompletedA study for evaluating the improvement effect on Metabolic dysfunction-associated steatotic liver disease (MASLD) of probiotics Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with dysbiosis of the gut microbiota and altered host metabolic homeosta…
Phase: PHASE1, PHASE2 • Sponsor: Chuncheon Sacred Heart Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a gene mutation predict immunotherapy success? virtual trial aims to find out
Knowledge-focused OngoingThis study is being done to see if patients with metastatic solid tumors (hematologic malignancies and lymphoma excluded) who have a specific genetic mutation in patients' tumor (the SF3B1, U2AF1 or SRSF2 mutation), are more likely to respond to immunotherapy agents that are now …
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New cancer drug shows promise in early safety trial
Disease control CompletedA phase I dose escalation and cohort expansion study to evaluate the safety, tolerance and pharmacokinetic of BAT1308 injection in patients with advanced solid tumors
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo aims to tackle tough prostate cancer
Disease control OngoingThis is a phase 1, open label, prospective, non-randomized single arm study combining Radium-223 with nivolumab in men with metastatic castration resistant prostate cancer.
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC